Progress in Liver Diseases

The three dimensional liver; the biology of hepatic endothelial cell fenestrae; the relation of mesenchymal cell products to hepatic epithelial systems; regulation of liver gene expression during various physiologic and pathophysiologic states; role of protooncogenes and transforming growth factors in normal and neoplastic liver growth; HLA-expression in liver disease; the acute phase response of the liver in inflammation; eicosanoids and the liver; cell-matrix interaction and hepatic fibrosis; application of nuclear magnetic resonance spectroscopy in experimental models and man; signal transduction and phosphoinositides metabolism in the liver; from albumin to the cytoplasm - the hepatic uptake of organic anions; glucuronidation of bilirubin; physiology of bile secretion and cholestasis; aspects of hepatic calcium metabolism; iron and the liver - genetic hemochromatosis and other hepatic iron overload disorders; genetic polymorphism of drug metabolism; effects of acetaldehyde on hepatic proteins; autoimmunity and liver disease; benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy; hepatitis A; expression of hepatitis B virus DNA sequences in cell culture; morphologic features of hepatitis B virus production in vitro;hepatitis B vacines; chronic hepatitis B; woodchuck hepatitis virus infection - a model of human hepatic diseases and hepatocellular carcinoma; hepatitis delta virus infection; enteric hepatitis non-A, non-B; the liver in HIV infection; primary biliary cirrhosis; the syndrome of primary sclerosing cholangitis; hepatobiliary consequences of parenteral alimentation; ageing and the liver; MRI of liver neoplasms; hepatocellular carcinoma in Alaska eskimos - epidemiology, clinical features and early detection; the post-operative problems and management of the liver transplant recipient; the pathology of liver transplantation.